+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ophthalmology Market Research Report by Diseases (Age-Related Macular Degeneration, Cataract, and Glaucoma), Product Type, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5336838
  • Report
  • April 2022
  • Region: Global
  • 211 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Alcon Inc.
  • CooperVision, Inc.
  • GenSight Biologics S.A.
  • Iris Pharma
  • Oxurion NV
  • Sensimed A.G.
The Global Ophthalmology Market size was estimated at USD 52.73 billion in 2021, USD 56.11 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.58% to reach USD 77.31 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Ophthalmology to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Diseases, the market was studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.
  • Based on Product Type, the market was studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers.
  • Based on End User, the market was studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ophthalmology market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ophthalmology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ophthalmology Market, including Aerie Pharmaceuticals, Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, ClearSight, CooperVision, Inc., Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., GenSight Biologics S.A., Glaukos Corporation, Hoya Corporation, Iris Pharma, Johnson & Johnson Vision, Kubota Pharmaceutical Holdings Co., Ltd., Nidek Co., Ltd., Oxurion NV, PanOptica, Inc., PharmOptima LLC, Sensimed A.G., Topcon Corporation, Unimed Pharma, Visioncare Optolab Pvt. Ltd., and Wellstat Therapeutics Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Ophthalmology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ophthalmology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ophthalmology Market?
4. What is the competitive strategic window for opportunities in the Global Ophthalmology Market?
5. What are the technology trends and regulatory frameworks in the Global Ophthalmology Market?
6. What is the market share of the leading vendors in the Global Ophthalmology Market?
7. What modes and strategic moves are considered suitable for entering the Global Ophthalmology Market?
Frequently Asked Questions about the Global Ophthalmology Market

What is the estimated value of the Global Ophthalmology Market?

The Global Ophthalmology Market was estimated to be valued at $52.7 Billion in 2021.

What is the growth rate of the Global Ophthalmology Market?

The growth rate of the Global Ophthalmology Market is 6.5%, with an estimated value of $77.3 Billion by 2027.

What is the forecasted size of the Global Ophthalmology Market?

The Global Ophthalmology Market is estimated to be worth $77.3 Billion by 2027.

Who are the key companies in the Global Ophthalmology Market?

Key companies in the Global Ophthalmology Market include Aerie Pharmaceuticals, Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, ClearSight, CooperVision, Inc., Essex Bio and EssilorLuxottica S.A..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alcon Inc.
  • CooperVision, Inc.
  • GenSight Biologics S.A.
  • Iris Pharma
  • Oxurion NV
  • Sensimed A.G.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Eye Disorders and Growing Awareness among the Population
5.1.1.2. Emerging Adoption of Prescription Glasses and Lenses
5.1.1.3. Presence of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
5.1.2. Restraints
5.1.2.1. High Cost of Treatment
5.1.3. Opportunities
5.1.3.1. Emerging Research Activities of Ophthalmology Treatments and Grants to Support Them
5.1.3.2. Technological Advancements in Ophthalmic Treatments and Devices
5.1.4. Challenges
5.1.4.1. Limited Skilled Professionals for Ophthalmic Procedures
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Ophthalmology Market, by Diseases
6.1. Introduction
6.2. Age-Related Macular Degeneration
6.3. Cataract
6.4. Glaucoma
6.5. Inflammatory Diseases
6.6. Refractive Disorders
7. Ophthalmology Market, by Product Type
7.1. Introduction
7.2. Drugs
7.2.1. Allergic Conjunctivitis & Inflammation Drugs
7.2.2. Dry Eye Drugs
7.2.3. Glaucoma Drugs
7.2.4. Retinal Disorder Drugs
7.3. Equipment
7.3.1. Diagnostic Devices
7.3.2. Surgical Devices
7.3.2.1. Intraocular Lenses
7.3.2.2. Ophthalmic Lasers
7.4. Prescription Glasses & Lens
7.5. Software
8. Ophthalmology Market, by End User
8.1. Introduction
8.2. Healthcare Service Providers
8.3. Hospitals
8.4. Medical Institutes
8.5. Research Organizations
9. Americas Ophthalmology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Ophthalmology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Ophthalmology Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Aerie Pharmaceuticals, Inc.
13.2. Alcon Inc.
13.3. Alkeus Pharmaceuticals, Inc.
13.4. Bausch & Lomb Incorporated
13.5. Carl Zeiss AG
13.6. ClearSight
13.7. CooperVision, Inc.
13.8. Essex Bio-Technology Limited
13.9. EssilorLuxottica S.A.
13.10. Eyenovia, Inc.
13.11. GenSight Biologics S.A.
13.12. Glaukos Corporation
13.13. Hoya Corporation
13.14. Iris Pharma
13.15. Johnson & Johnson Vision
13.16. Kubota Pharmaceutical Holdings Co., Ltd.
13.17. Nidek Co., Ltd.
13.18. Oxurion NV
13.19. PanOptica, Inc.
13.20. PharmOptima LLC
13.21. Sensimed A.G.
13.22. Topcon Corporation
13.23. Unimed Pharma
13.24. Visioncare Optolab Pvt. Ltd.
13.25. Wellstat Therapeutics Corporation
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL OPHTHALMOLOGY MARKET: DYNAMICS
FIGURE 2. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2021 VS 2027 (%)
FIGURE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2027
FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, 2019-2027 (USD BILLION)
FIGURE 35. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, 2019-2027 (USD BILLION)
FIGURE 37. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 38. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, 2019-2027 (USD BILLION)
FIGURE 39. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, 2019-2027 (USD BILLION)
FIGURE 41. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 42. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 43. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2027
FIGURE 45. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, 2019-2027 (USD BILLION)
FIGURE 46. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 47. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, 2019-2027 (USD BILLION)
FIGURE 48. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 49. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, 2019-2027 (USD BILLION)
FIGURE 50. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 51. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2019-2027 (USD BILLION)
FIGURE 52. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 53. AMERICAS OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. ARGENTINA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. BRAZIL OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. CANADA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. MEXICO OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. UNITED STATES OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. CHINA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. INDIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. INDONESIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. JAPAN OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. MALAYSIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. SINGAPORE OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. TAIWAN OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. THAILAND OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. FRANCE OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. GERMANY OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. ITALY OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. QATAR OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. RUSSIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 79. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 80. SPAIN OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 81. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. GLOBAL OPHTHALMOLOGY MARKET: FPNV POSITIONING MATRIX
FIGURE 84. GLOBAL OPHTHALMOLOGY MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OPHTHALMOLOGY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL OPHTHALMOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 31. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 33. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 36. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 38. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 56. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 58. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 66. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 68. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2019-2027 (USD BILLION)
TABLE 71. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY STATE, 2019-2027 (USD BILLION)
TABLE 73. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 75. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 76. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 77. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 78. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 80. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2019-2027 (USD BILLION)
TABLE 81. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 82. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY STATE, 2019-2027 (USD BILLION)
TABLE 83. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 85. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2019-2027 (USD BILLION)
TABLE 86. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 87. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY STATE, 2019-2027 (USD BILLION)
TABLE 88. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 90. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 91. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 92. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 93. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 94. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 96. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD BILLION)
TABLE 97. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 98. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD BILLION)
TABLE 99. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 101. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2019-2027 (USD BILLION)
TABLE 102. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 103. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY STATE, 2019-2027 (USD BILLION)
TABLE 104. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 106. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD BILLION)
TABLE 107. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 108. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY STATE, 2019-2027 (USD BILLION)
TABLE 109. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 111. AMERICAS OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 112. ARGENTINA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 113. BRAZIL OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 114. CANADA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 115. MEXICO OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. UNITED STATES OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 117. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 118. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 119. CHINA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 120. INDIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 121. INDONESIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 122. JAPAN OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 123. MALAYSIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 124. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 125. SINGAPORE OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 126. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 127. TAIWAN OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 128. THAILAND OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 130. FRANCE OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 131. GERMANY OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 132. ITALY OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 133. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 134. QATAR OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 135. RUSSIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 136. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 137. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 138. SPAIN OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 139. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 140. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 141. GLOBAL OPHTHALMOLOGY MARKET: SCORES
TABLE 142. GLOBAL OPHTHALMOLOGY MARKET: BUSINESS STRATEGY
TABLE 143. GLOBAL OPHTHALMOLOGY MARKET: PRODUCT SATISFACTION
TABLE 144. GLOBAL OPHTHALMOLOGY MARKET: RANKING
TABLE 145. GLOBAL OPHTHALMOLOGY MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 146. GLOBAL OPHTHALMOLOGY MARKET: MERGER & ACQUISITION
TABLE 147. GLOBAL OPHTHALMOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 148. GLOBAL OPHTHALMOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 149. GLOBAL OPHTHALMOLOGY MARKET: INVESTMENT & FUNDING
TABLE 150. GLOBAL OPHTHALMOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 151. GLOBAL OPHTHALMOLOGY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Aerie Pharmaceuticals, Inc.
  • Alcon Inc.
  • Alkeus Pharmaceuticals, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss AG
  • ClearSight
  • CooperVision, Inc.
  • Essex Bio-Technology Limited
  • EssilorLuxottica S.A.
  • Eyenovia, Inc.
  • GenSight Biologics S.A.
  • Glaukos Corporation
  • Hoya Corporation
  • Iris Pharma
  • Johnson & Johnson Vision
  • Kubota Pharmaceutical Holdings Co., Ltd.
  • Nidek Co., Ltd.
  • Oxurion NV
  • PanOptica, Inc.
  • PharmOptima LLC
  • Sensimed A.G.
  • Topcon Corporation
  • Unimed Pharma
  • Visioncare Optolab Pvt. Ltd.
  • Wellstat Therapeutics Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...